Charles River Laboratories International Q2 Earnings Call Highlights
MarketBeat
Charles River Laboratories International (NYSE:CRL) reported second-quarter results that exceeded its prior outlook, citing improved demand in its Discovery and Safety Assessment, or DSA, business and stronger-than-expected manufacturing performance. The company raised its full-year revenue, earning
NYSE:CRL